A Randomized, Double-blind, Multi-center, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel (DSG) 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain.
Phase of Trial: Phase III
Latest Information Update: 03 Sep 2012
At a glance
- Drugs Diclofenac (Primary)
- Indications Musculoskeletal pain
- Focus Therapeutic Use
- 06 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Dec 2010 New trial record